| Literature DB >> 29849078 |
Li-Jun Zuo1, Zi-Xiao Li1,2, Rong-Yan Zhu1, Yao-Jing Chen3, YanHong Dong4,5, Yi-Long Wang1,2,6, Xing-Quan Zhao1,2,7, Zhan-Jun Zhang3, Perminder Sachdev5,8, Wei Zhang1,2,9,10,11,12, Yong-Jun Wang13,14,15,16.
Abstract
Mild stroke is a known risk factor for dementia. The relationship between cerebral white matter (WM) integrity and cognitive impairment (CI) in mild stroke patients with basal ganglia region infarcts is unknown. Total of 33 stroke patients and 19 age-matched controls underwent diffusion tensor imaging scans and a formal neuropsychological test battery. CI was defined as having a performance score 1.5 SD below the established norm. We compared the differences in Z-scores and Fraction Anisotropy (FA) values among controls, stroke with no CI (NCI) and stroke with CI groups. Multiple linear regressions were performed between FA values in affected regions and neuropsychological tests in stroke patients. The majority of stroke patients were in their 50s (56.90 ± 9.23 years). CI patients exhibited a significantly decreased Z score in visual delayed memory and remarkably decreased FA values in the right external capsule and right fornix (FWE-corrected) compared with NCI patients and controls. In stroke patients, the FA value in the right fornix was positively correlated with delayed visual memory. Mild stroke with basal ganglia region infarcts may be related to widespread abnormality of WM integrity. The lower WM integrity in the right fornix may be a marker of impaired delayed visual memory.Entities:
Mesh:
Year: 2018 PMID: 29849078 PMCID: PMC5976674 DOI: 10.1038/s41598-018-26316-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Demographic information of the control group, NCI group and CI group.
| Control group (n = 19 cases) | NCI group (n = 13 cases) | CI group (n = 20 cases) | p1 value | p2 value | p3 value | |
|---|---|---|---|---|---|---|
| Age (years, mean ± SD) | 50.74 ± 7.37 | 54.61 ± 9.11 | 48.15 ± 8.32 | 0.40 | 0.17 | 0.06 |
| Sex (male/total, %) | 13/19 (68.42) | 11/13 (84.62) | 16/20 (80.00) | 0.40 | 0.48 | |
| Education (years, mean ± SD) | 10.68 ± 2.38 | 9.40 ± 1.73 | 10.84 ± 1.99 | 0.84 | 0.06 | 0.04 |
| NIHSS at admonition [scores, median (IQR)] | — | 2.00 (2.50) | 2.00 (2.75) | — | — | 0.43 |
| Functional status (Modified Rankin Scale; [scores, median (IQR)]) | — | 1.00 (2.00) | 1.00 (1.00) | — | — | 0.37 |
| IQCODE(scores, mean ± SD) | 3.07 ± 0.11 | 3.09 ± 0.06 | 3.12 ± 0.14 | 0.58 | 0.17 | 0.5 |
| HAMD (scores, mean ± SD) | 2.15 ± 2.38 | 2.14 ± 2.32 | 2.63 ± 2.41 | 0.19 | 0.08 | 0.86 |
| Right-handedness (cases/total, %) | 18/19 (94.74) | 12/13 (92.31) | 18/20 (90.00) | 1.00 | 0.52 | 1.00 |
| Instrumental ADL (scores, mean ± SD) | 8.00 ± 0.00 | 8.29 ± 0.73 | 8.37 ± 0.90 | 0.17 |
|
|
| Basic ADL (scores, mean ± SD) | 6.00 ± 0.00 | 6.00 ± 0.00 | 6.07 ± 0.27 | 0.34 | 0.99 | 0.34 |
|
| ||||||
|
| — | — | — |
| ||
|
| — | — | — |
| ||
| Diameter of lesion (mm, mean ± SD) | — | 14.55 ± 4.74 | 19.02 ± 9.64 | — | — | 0.09 |
| Left basal ganglia (cases/total, %) | — | 10/13 (76.92) | 12/20 (60.00) | — | — | 0.27 |
| Hypertension (cases/total, %) | 13/19 (68.42) | 9/13 (69.23) | 14/20 (70.00) | 1.00 | 1.00 | 1.00 |
| Impaired glucose regulation (cases/total, %) | 3/19 (15.79) | 2/13 (15.38) | 6/20 (30.00) | 1.00 | 0.45 | 0.43 |
| Hyperlipidemia (cases/total, %) | 10/19 (52.63) | 8/13 (61.54) | 16/20 (80.00) | 0.73 | 0.10 | 0.43 |
| Hyperhomocysteinemia (cases/total, %) | 9/19 (47.37) | 6/13 (46.15) | 6/20 (30.00) | 1.00 | 0.33 | 0.47 |
| Peripheral arterial disease (cases/total, %) | 2/19 (10.53) | 3/13 (23.08) | 2/20 (10.00) | 0.37 | 1.00 | 0.36 |
| Current or ever drinking (cases/total, %) | 8/19 (42.11) | 10/13 (76.92) | 14/20 (70.00) | 0.08 | 0.11 | 1.00 |
| Current or ever smoking (cases/total, %) | 8/19 (42.11) | 8/13 (61.54) | 12/20 (60.00) | 0.47 | 0.34 | 1.00 |
| Family history of stroke (cases/total, %) | 1/19 (5.26) | 1/13 (7.69) | 2/20 (10.00) | 1.00 | 1.00 | 1.00 |
| Posterior circulation (case/total, %) | — | 4/13 (30.77) | 2/20 (10.00) | — | — | 0.18 |
NCI, no cognitive impairment; CI, cognitive impairment; NIHSS, National Institute of Health Stroke Scale; HAMD, Hamilton Depression Rating Score; ADL, Activities of Daily Living Scale; LAA, large atherothrombotic infarction; *p < 0.017, **p < 0.01. p1: NCI group vs. control group; p2: CI group vs. control group; p3: NCI group vs. CI group.
Comparison of Z-scores in cognitive function among the control group, NCI group and CI group.
| Cognitive function | Controls (19 cases) | NCI group (13 cases) | CI group (20 cases) | p1 value | p2 value | p3 value |
|---|---|---|---|---|---|---|
|
| 1.081 (3.053) | −2.674 (4.781) | −3.901 (4.182) | 0.472 |
| 0.394 |
| Total score of AVLT | 0.502 (1.881) | −0.500 (2.125) | −1.000 (2.800) | 0.250 |
| 0.668 |
| AVLT-delayed recall | 0.001 (2.000) | −1.000 (2.500) | −1.000 (2.000) | 0.472 | 0.046 | 0.873 |
|
| 0.171 (1.502) | −0.750 (1.417) | −2.250 (1.625) | 0.892 |
|
|
| RCFT−delayed recall | 0.171 (1.502) | −0.750 (1.417) | −2.250 (1.625) | 0.892 |
|
|
|
| 0.500 (0.500) | −1.500 (1.000) | −1.750 (4.875) | 0.192 |
| 0.378 |
| RCFT | 0.500 (0.500) | −1.500 (1.000) | −1.750 (4.875) | 0.192 |
| 0.378 |
|
| 2.331 (2.751) | 1.167 (4.292) | −1.082 (2.749) | 0.991 |
| 0.117 |
| BNT | 1.331 (1.001) | 0.667 (2.200) | 0.000 (1.333) | 0.250 | 0.116 | 0.472 |
| AFT | 2.003 (1.251) | −0.250 (1.375) | −0.625 (1.688) | 0.031 |
| 0.394 |
|
| 1.204 (0.503) | −1.100 (1.800) | −1.500 (2.000) |
|
| 0.472 |
| SDMT | 1.204 (0.503) | −1.100 (1.800) | −1.500 (2.000) |
|
| 0.472 |
|
| 4.575 (2.917) | 2.117 (6.715) | −1.629 (5.379) | 0.472 |
| 0.394 |
| TMT-A time | 1.461 (0.104) | −0.717 (1.232) | −1.292 (2.013) | 0.668 |
| 0.023 |
| TMT-B time | 1.232 (0.652) | −0.225 (2.600) | −1.375 (2.517) | 0.150 |
| 0.188 |
| CWT-C time | 0.961 (0.252) | −0.333 (1.600) | −0.364 (2.136) | 0.061 | 0.024 | 0.998 |
| CWT-C correct numbers | 0.000 (3.500) | 2.500 (1.000) | 3.000 (1.375) | 0.151 | 0.029 | 0.734 |
AVLT, Auditory Verbal Learning Test; RCFT, Rey-Osterrieth Complex Figure Test; BNT, Boston Naming Test; AFT, Animal Fluency Test; SDMT, Symbol Digit Modalities Test; TMT-A, Chinese modified version of the Trail Making Test; CWT-C, Color-Word Test-Chinese version; *p < 0.017,**p < 0.01. p1: NCI group vs. control group; p2: CI group vs. control group; p3: NCI group vs. CI group.
Figure 1Group comparisons of tract-based spatial statistics (TBSS). Yellow and red indicate WM tracts with significantly decreased FA values. Green indicates WM tracts with no significantly decreased FA values. (A) TBSS results among the control group, mild stroke with cognitive impairment (CI) group and mild stroke with no cognitive impairment (NCI) group. The results showed decreased FA values in most brain regions. (B) TBSS results between the NCI group and the control group. Decreased FA values were detected in the genu, body and splenium of the corpus callosum, fornix, bilateral corticospinal tract, superior longitudinal fasciculus, inferior fronto-occipital fasciculus, anterior limb of internal capsule, right anterior corona radiate, posterior thalamic radiation, external capsule and left superior corona radiate (p < 0.05, FWE-corrected). (C) TBSS results between the CI group and the control group. Decreased FA values were visible in the genu, body and splenium of the corpus callosum, fornix, bilateral anterior corona radiate, inferior fronto-occipital fasciculus and superior longitudinal fasciculus, left corticospinal tract, left cerebral peduncle, left posterior limb of internal capsule and right external capsule (p < 0.05, FWE-corrected). There was no significant difference in FA values of brain regions between the CI group and the NCI group according to TBSS analysis.
Figure 2Correlations between the atlas-based regions of interest FA and neuropsychological tests scores in basal ganglia mild stroke patients. RCFT-delayed recall indicates Rey-Osterrieth Complex Figure Test-delayed recall.
Comparison of important MRI manifestations of cerebral small vessel disease among the control group, NCI group and CI group.
| control group (19 cases) | NCI group v(13 cases) | CI group (20 cases) | p1 value | p2 value | p3 value | |
|---|---|---|---|---|---|---|
|
| 19/19 (100.00) | 13/13 (100.00) | 17/20 (85.00) | 1.00 | 0.23 | 0.26 |
| Periventricular white matter hyperintensities [cases/total (%)] | 19/19 (100.00) | 13/13 (100.00) | 17/20 (85.00) | 1.00 | 0.23 | 0.26 |
| Fazekas scores [scores, median (quartile)] | 1.00 (0.00) | 2.00 (0.00) | 1.00 (0.75) | 0.04 | 0.45 | 0.02 |
| Deep white matter hyperintensities [cases/total (%)] | 5/19 (26.32) | 9/13 (69.23) | 6/20 (30.00) | 0.03 | 1.00 | 0.04 |
| Fazekas scores [scores, median (quartile)] | 0.00 (1.00) | 0.00 (1.00) | 1.00 (1.00) | 0.87 | 0.92 | 0.03 |
|
| 7/19 (36.84) | 9/13 (69.23) | 14/20 (70.00) | 0.15 | 0.06 | 1.00 |
| Basal ganglia [cases/total (%)] | 7/19 (36.84) | 6/13 (46.15) | 11/20 (55.00) | 0.72 | 0.33 | 0.73 |
| Subcortical regions [cases/total (%)] | 3/19 (15.79) | 4/13 (30.77) | 5/20 (25.00) | 0.40 | 0.70 | 1.00 |
| Subtentorial regions [cases/total (%)] | 0/19 (0.00) | 4/13 (30.77) | 4/20 (20.00) | 0.02 | 0.11 | 0.68 |
| Cortex [cases/total (%)] | 0/19 (0.00) | 1/13 (7.69) | 6/20 (30.00) | 0.41 | 0.02 | 0.20 |
|
| 19/19 (100.00) | 13/13 (100.00) | 20/20 (100.00) | 1.00 | 1.00 | 1.00 |
| Basal ganglia [cases/total (%)] | 3.00 (3.00) | 2.00 (1.00) | 2.00 (2.00) | 0.73 | 0.71 | 0.54 |
| Cortex [cases/total (%)] | 4.00 (1.00) | 2.00 (3.00) | 4.00 (0.50) | 0.43 | 0.15 | 0.02 |
|
| 0/19 (0.00) | 0/13 (0.00) | 0/20 (0.00) | 1.00 | 1.00 | 1.00 |
p1: NCI group vs. control group; p2: CI group vs. control group; p3: NCI group vs. CI group.